MYDA Advisors LLC
- SEC CIK
- 0001589689
- Latest filing
- Aug 13, 2026
CRVS holding history
Corvus Pharmaceuticals, Inc. in every 13F filed by MYDA Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −71,011−100.0% | Sold out | Holders |
| Q4 2023 | 71,011 | $125.0K | 0.1% | +2,197+3.2% | Added | Holders |
| Q3 2023 | 68,814 | $100.5K | <0.1% | −31,186−31.2% | Reduced | Holders |
| Q2 2023 | 100,000 | $229.0K | 0.1% | +100,000 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −60,000−100.0% | Sold out | Holders |
| Q3 2021 | 60,000 | $290.0K | 0.1% | +60,000 | New | Holders |